Svai Sanford
Director of Finance/CFO chez RANI THERAPEUTICS HOLDINGS, INC.
Fortune : 1 M $ au 31/03/2024
Profil
Svai S.
Sanford is currently the Chief Financial Officer at Rani Therapeutics LLC, Rani Therapeutics Holdings, Inc., and Rani Management Services, Inc. In the past, he worked as the Chief Financial & Accounting Officer at VIVUS, Inc. from 2013 to 2015, the Chief Financial Officer at SFJ Pharmaceuticals, Inc. from 2015 to 2017, and the Chief Financial Officer at Ph Pharma, Inc. from 2017 to 2018.
He also worked as a Member at KPMG LLP from 1996 to 2002 and as the Chief Operating Officer at Altavant Sciences, Inc. He received his undergraduate degree from Kansas State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
Rani Therapeutics LLC
 Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. 0,72% | 29/07/2021 | 221 408 ( 0,72% ) | 688 579 $ | 31/03/2024 |
| 31/03/2023 | 142 350 ( inf% ) | 442 709 $ | 31/03/2024 | |
| 21/03/2024 | 41 822 ( 0,16% ) | 130 066 $ | 31/03/2024 |
Postes actifs de Svai Sanford
| Sociétés | Poste | Début |
|---|---|---|
| RANI THERAPEUTICS HOLDINGS, INC. | Director of Finance/CFO | 06/04/2021 |
Rani Therapeutics LLC
Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | Director of Finance/CFO | - |
| Rani Management Services, Inc. | Director of Finance/CFO | - |
Anciens postes connus de Svai Sanford
| Sociétés | Poste | Fin |
|---|---|---|
Ph Pharma, Inc.
 Ph Pharma, Inc. BiotechnologyHealth Technology PH Pharma, Inc. is a healthcare platform company that is dedicated to developing innovative products. The private company is based in South San Francisco, CA. The company's pipeline includes first-in-class therapeutic agents for the aging population and unmet markets. The company is also developing multiple novel anticancer toxin categories that have unique mechanisms of action and are poised to improve the therapeutic index of existing toxins. | Director of Finance/CFO | 01/11/2018 |
SFJ Pharmaceuticals, Inc.
 SFJ Pharmaceuticals, Inc. BiotechnologyHealth Technology SFJ Pharmaceuticals, Inc. develops pharmaceuticals drugs. It offers drugs for cancer, kidney, thyroid, leukemia, and lung cancer. The company was founded by Roberto DeBenedetto in January 2009 and is headquartered in Pleasanton, CA. | Director of Finance/CFO | 01/03/2017 |
| VIVUS, INC. | Director of Finance/CFO | 30/09/2015 |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/2002 |
Altavant Sciences, Inc.
 Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | Chief Operating Officer | - |
Formation de Svai Sanford
| Kansas State University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| RANI THERAPEUTICS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Commercial Services |
SFJ Pharmaceuticals, Inc.
SFJ Pharmaceuticals, Inc. BiotechnologyHealth Technology SFJ Pharmaceuticals, Inc. develops pharmaceuticals drugs. It offers drugs for cancer, kidney, thyroid, leukemia, and lung cancer. The company was founded by Roberto DeBenedetto in January 2009 and is headquartered in Pleasanton, CA. | Health Technology |
Rani Therapeutics LLC
Rani Therapeutics LLC Pharmaceuticals: MajorHealth Technology Rani Therapeutics LLC develops a oral biotherapeutics technology for the oral delivery of drug molecules, including peptides, proteins, and antibodies. Its products include TNFa Inhibitors, Parathyroid Hormone, Human Growth Hormone, Somatostatin, and Basal Insulin. The company is headquartered in San Jose, CA. | Health Technology |
Altavant Sciences, Inc.
Altavant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Altavant Sciences, Inc. is a clinical stage biopharmaceutical company, which provides therapies that treat respiratory diseases with an initial therapeutic focus in pulmonary arterial hypertension (PAH). The company is headquartered in Cary, NC. | Health Technology |
| Rani Management Services, Inc. | |
Ph Pharma, Inc.
Ph Pharma, Inc. BiotechnologyHealth Technology PH Pharma, Inc. is a healthcare platform company that is dedicated to developing innovative products. The private company is based in South San Francisco, CA. The company's pipeline includes first-in-class therapeutic agents for the aging population and unmet markets. The company is also developing multiple novel anticancer toxin categories that have unique mechanisms of action and are poised to improve the therapeutic index of existing toxins. | Health Technology |
